Aspen Pharmacare Holdings Ltd

ZA

APNJ

Health Care

11.59 ₽

Current price

Strong sell
11.59 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    660 / 1328

  • Position in country

    253 / 336

  • Return on Assets, %

    3.6

    -2.7

  • Net income margin, %

    10.9

    2.8

  • EBITDA margin, %

    24.5

    10.8

  • Debt to Equity, %

    42.1

    19.2

  • Intangible assets and goodwill, %

    52.8

    3.6

  • Revenue CAGR 3Y, %

    6.5

    8.5

  • Revenue Y, % chg

    -0.3

    0.5

  • P/E

    20

    22.7

  • P/BV

    1.1

    1.5

  • P/S

    2.2

    2.3

  • EV/S

    2.8

    2.4

  • EV/EBITDA

    14.9

    7.4

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    6.5

    51.3

  • Forward P/E

    12.1

    15.6

  • Dividend Yield, %

    1.5

    1.7

  • Forward Dividend Yield, %

    2

    0.2

  • Expected dividend per share

    0.2

    0

  • Dividend Ex Date

    2023-09-21

Get an analytical review of this company

Competitors

Ranks

  • Novo Nordisk A/S

    00%

  • Sanofi SA

    00%

  • AstraZeneca PLC

    00%

  • Eli Lilly and Co

    00%

  • Roche Holding AG

    00%

  • Aspen Pharmacare Holdings Ltd

    00%

  • Novartis AG

    00%

  • Johnson & Johnson

    00%

  • Merck & Co Inc

    00%

  • Pfizer Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    South Africa

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    5239.9

  • Ticker

    APNHY.PK

  • ISIN

    US04530Y1064

  • IPO date

    1994-12-05

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-04

  • Date fact. publication of reports

    2023-12-31

Company Description

Aspen Pharmacare Holdings Limited is a South Africa-based global specialty and branded pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both active pharmaceutical ingredients (APIs) and finished dose form. The Company is focused on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through its key business segments: Manufacturing and Commercial Pharmaceuticals. The Manufacturing segment relates to the manufacture and sale of APIs and finished dose form products to third-party customers. Its Commercial Pharmaceuticals segment comprises Regional Brands and Sterile Focus Brands that include Anaesthetics and Thrombosis products. It operates approximately 23 manufacturing facilities on six continents. Its manufacturing capabilities cover a wide variety of product-types, including orals, liquids, steriles, biologicals and APIs.